Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11866435 Heterocyclic compounds as immunomodulators

Patent 11866435 was granted and assigned to Incyte on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Liangxing Wu0

Neil Lajkiewicz0

Wenqing Yao0

Date of Patent

January 9, 2024

0

Patent Application Number

179923990

Date Filed

November 22, 2022

0

Patent Citations

US Patent 7691870 Benzimidazole carboxamides as raf kinase inhibitors

0

US Patent 7851489 Pyridinone compounds

0

US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

0

US Patent 6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors

0

US Patent 7320989 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

0

US Patent 7417065 Immunosuppressant compounds and compositions

0

US Patent 7488802 Antibodies against PD-1

0

US Patent 7491245 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof

0

...

Patent Citations Received

US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor

0

Patent Primary Examiner

D Margaret M Seaman

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11866435 Heterocyclic compounds as immunomodulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool